Haemonetics (HAE) Total Current Liabilities (2010 - 2026)
Haemonetics (HAE) posted quarterly Total Current Liabilities of $282.6 million for Q1 2026, down 51.12% year-over-year from $578.1 million in Q1 2025, and down 47.65% quarter-over-quarter from $539.9 million in Q4 2025.
Haemonetics (HAE) Total Current Liabilities (2010 - 2026) Analysis & Trends
Haemonetics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $282.6 million for Q1 2026.
- In Q1 2026, Total Current Liabilities fell 51.12% year-over-year to $282.6 million; the TTM figure through Mar 2026 stood at $282.6 million (down 51.12% YoY), while the FY2026 annual figure was $282.6 million, down 51.12% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $282.6 million, down from $539.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $578.1 million in Q1 2025, with the low at $180.5 million in Q3 2022.
- The 5-year median for Total Current Liabilities is $269.1 million (2023), against an average of $336.1 million.
- The sharpest annual moves came in 2025 and 2026: Total Current Liabilities soared 113.19% in 2025, then plunged 51.12% in 2026.
- Haemonetics' Total Current Liabilities stood at $226.9 million in 2022, then increased by 15.37% to $261.8 million in 2023, then retreated by 3.26% to $253.2 million in 2024, then jumped by 113.19% to $539.9 million in 2025, then plunged by 47.65% to $282.6 million in 2026.
- Business Quant data shows HAE's Total Current Liabilities at $282.6 million in Q1 2026, $539.9 million in Q4 2025, and $548.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn | 263.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 263.24 Mn |
| Mar 28, 2026 | 282.60 Mn |
| Dec 27, 2025 | 539.87 Mn |
| Sep 27, 2025 | 548.32 Mn |
| Jun 28, 2025 | 531.41 Mn |
| Mar 29, 2025 | 578.11 Mn |
| Dec 28, 2024 | 253.23 Mn |
| Sep 28, 2024 | 273.95 Mn |
| Jun 29, 2024 | 260.08 Mn |
| Mar 30, 2024 | 300.38 Mn |
| Dec 30, 2023 | 261.76 Mn |
| Sep 30, 2023 | 264.22 Mn |
| Jul 1, 2023 | 236.94 Mn |
| Apr 1, 2023 | 251.82 Mn |
| Dec 31, 2022 | 226.89 Mn |
| Oct 1, 2022 | 262.18 Mn |
| Jul 2, 2022 | 180.49 Mn |
| Apr 2, 2022 | 442.27 Mn |
| Jan 1, 2022 | 355.41 Mn |
| Oct 2, 2021 | 288.47 Mn |